Zhangzhou Pientzehuang Pharmaceutical announces interim dividend plan

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. announced its 2025 interim profit distribution plan, proposing a cash dividend of CNY 1.40 per 10 shares (including tax). This totals CNY 844,644,094.00, representing 58.56% of the net profit attributable to shareholders in the 2025 semi-annual consolidated report. The company confirmed this distribution will not involve bonus shares or a capital reserve transfer.

The interim profit distribution plan was approved at board and supervisory meetings held on August 28, 2025, following authorization from the 2024 annual general meeting on June 20, 2025.

The company’s 2025 semi-annual report shows total assets of CNY 18,708,792,009.00 and net assets attributable to shareholders of CNY 14,624,557,775.97 as of June 30, 2025. Operating income for the period was CNY 5,378,537,133.95, with a total profit of CNY 1,705,759,306.42. The board of supervisors affirmed the proposed distribution aligns with legal requirements, considering the company’s operating performance, cash flow, and capital needs.